{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T09:59:27Z","timestamp":1768039167492,"version":"3.49.0"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2014,12,15]],"date-time":"2014-12-15T00:00:00Z","timestamp":1418601600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0115429","type":"journal-article","created":{"date-parts":[[2014,12,15]],"date-time":"2014-12-15T18:56:03Z","timestamp":1418669763000},"page":"e115429","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":45,"title":["Urinary Excretion of Fatty Acid-Binding Protein 4 is Associated with Albuminuria and Renal Dysfunction"],"prefix":"10.1371","volume":"9","author":[{"given":"Yusuke","family":"Okazaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Furuhashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marenao","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Mita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Fuseya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shutaro","family":"Ishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoko","family":"Hoshina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Akasaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Ohnishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeyuki","family":"Saitoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuaki","family":"Shimamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuji","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,12,15]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrd2589","article-title":"Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets","volume":"7","author":"M Furuhashi","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"642612","DOI":"10.4061\/2011\/642612","article-title":"Lipid chaperones and metabolic inflammation","volume":"2011","author":"M Furuhashi","year":"2011","journal-title":"Int J Inflam"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1042\/bj2880285","article-title":"Molecular identification of the liver- and the heart-type fatty acid-binding proteins in human and rat kidney. Use of the reverse transcriptase polymerase chain reaction","volume":"288 (Pt 1)","author":"RG Maatman","year":"1992","journal-title":"Biochem J"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2006.05.038","article-title":"Urinary fatty acid binding protein in renal disease","volume":"374","author":"A Kamijo-Ikemori","year":"2006","journal-title":"Clin Chim Acta"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"F669","DOI":"10.1152\/ajprenal.90513.2008","article-title":"Urinary fatty acid-binding protein 1: an early predictive biomarker of kidney injury","volume":"296","author":"E Noiri","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.2337\/dc12-1298","article-title":"Predictive effects of urinary liver-type fatty acid-binding protein for deteriorating renal function and incidence of cardiovascular disease in type 2 diabetic patients without advanced nephropathy","volume":"36","author":"S Araki","year":"2013","journal-title":"Diabetes Care"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cca.2011.09.018","article-title":"Urinary excretion of liver-type fatty acid-binding protein as a marker of progressive kidney function deterioration in patients with chronic glomerulonephritis","volume":"413","author":"S Mou","year":"2012","journal-title":"Clin Chim Acta"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1126\/science.274.5291.1377","article-title":"Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein","volume":"274","author":"GS Hotamisligil","year":"1996","journal-title":"Science"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/89076","article-title":"Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis","volume":"7","author":"L Makowski","year":"2001","journal-title":"Nat Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cmet.2004.12.008","article-title":"Adipocyte\/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes","volume":"1","author":"K Maeda","year":"2005","journal-title":"Cell Metab"},{"key":"ref11","first-page":"2640","article-title":"Adipocyte\/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice","volume":"118","author":"M Furuhashi","year":"2008","journal-title":"J Clin Invest"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/nature05844","article-title":"Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2","volume":"447","author":"M Furuhashi","year":"2007","journal-title":"Nature"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.cmet.2013.04.012","article-title":"Adipocyte lipid chaperone AP2 is a secreted adipokine regulating hepatic glucose production","volume":"17","author":"H Cao","year":"2013","journal-title":"Cell Metab"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1373\/clinchem.2005.062463","article-title":"Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome","volume":"52","author":"A Xu","year":"2006","journal-title":"Clin Chem"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1161\/CIRCULATIONAHA.106.647503","article-title":"Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study","volume":"115","author":"A Xu","year":"2007","journal-title":"Circulation"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.2337\/dc07-0413","article-title":"Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort","volume":"30","author":"AW Tso","year":"2007","journal-title":"Diabetes Care"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1161\/ATVBAHA.107.146274","article-title":"Serum adipocyte fatty acid-binding protein levels were independently associated with carotid atherosclerosis","volume":"27","author":"DC Yeung","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/ajh.2012.88","article-title":"Elevation of fatty acid-binding protein 4 is predisposed by family history of hypertension and contributes to blood pressure elevation","volume":"25","author":"H Ota","year":"2012","journal-title":"Am J Hypertens"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e81318","DOI":"10.1371\/journal.pone.0081318","article-title":"Circulating levels of fatty acid-binding protein family and metabolic phenotype in the general population","volume":"8","author":"S Ishimura","year":"2013","journal-title":"PLoS ONE"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12933-014-0126-7","article-title":"Elevation of circulating fatty acid-binding protein 4 is independently associated with left ventricular diastolic dysfunction in a general population","volume":"13","author":"T Fuseya","year":"2014","journal-title":"Cardiovasc Diabetol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1096\/fj.09-134882","article-title":"Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells","volume":"23","author":"H Elmasri","year":"2009","journal-title":"FASEB J"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1161\/ATVBAHA.113.301588","article-title":"Capillary endothelial fatty acid binding proteins 4 and 5 play a critical role in fatty acid uptake in heart and skeletal muscle","volume":"33","author":"T Iso","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Tanaka M, Furuhashi M, Okazaki Y, Mita T, Fuseya T, <etal>et al<\/etal>. (2014) Ectopic expression of fatty acid-binding protein 4 in the glomerulus is associated with proteinuria and renal dysfunction. Nephron Clin Paract [doi: ]<ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/dx.doi.org\/10.1159\/000368412\" xlink:type=\"simple\">10.1159\/000368412]<\/ext-link>. (in press).","DOI":"10.1159\/000368412"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.lab.2003.08.001","article-title":"Urinary fatty acid-binding protein as a new clinical marker of the progression of chronic renal disease","volume":"143","author":"A Kamijo","year":"2004","journal-title":"J Lab Clin Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"S Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1161\/ATVBAHA.107.141705","article-title":"Genomic changes in regenerated porcine coronary arterial endothelial cells","volume":"27","author":"MY Lee","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Mita T, Furuhashi M, Hiramitsu S, Ishii J, Hoshina K, <etal>et al<\/etal>. (2014) FABP4 is secreted from adipocytes by adenyl cyclase-PKA- and guanylyl cyclase-PKG-dependent lipolytic mechanisms. Obesity [doi: ]<ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/dx.doi.org\/10.1002\/oby.20954\" xlink:type=\"simple\">10.1002\/oby.20954]<\/ext-link>. (in press).","DOI":"10.1002\/oby.20954"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1530\/EJE-10-1195","article-title":"FABP 4 is associated with inflammatory markers and metabolic syndrome in morbidly obese women","volume":"164","author":"X Terra","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e27356","DOI":"10.1371\/journal.pone.0027356","article-title":"Serum fatty acid-binding protein 4 is a predictor of cardiovascular events in end-stage renal disease","volume":"6","author":"M Furuhashi","year":"2011","journal-title":"PLoS ONE"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1161\/ATVBAHA.112.248609","article-title":"Circulating adipocyte fatty acid-binding protein levels and cardiovascular morbidity and mortality in patients with coronary heart disease: a 10-year prospective study","volume":"32","author":"M von Eynatten","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e004176","DOI":"10.1161\/JAHA.112.004176","article-title":"Elevated circulating adipocyte-fatty acid binding protein levels predict incident cardiovascular events in a community-based cohort: a 12-year prospective study","volume":"2","author":"WS Chow","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1475-2840-11-72","article-title":"Fatty acid-binding protein 4 impairs the insulin-dependent nitric oxide pathway in vascular endothelial cells","volume":"11","author":"G Aragones","year":"2012","journal-title":"Cardiovasc Diabetol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nrneph.2013.78","article-title":"The role of the podocyte in albumin filtration","volume":"9","author":"PT Brinkkoetter","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"F947","DOI":"10.1152\/ajprenal.90601.2008","article-title":"Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier","volume":"296","author":"SC Satchell","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e55027","DOI":"10.1371\/journal.pone.0055027","article-title":"Glomerular endothelial cell injury and damage precedes that of podocytes in adriamycin-induced nephropathy","volume":"8","author":"YB Sun","year":"2013","journal-title":"PLoS ONE"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.2337\/db07-0019","article-title":"Podocyte detachment and reduced glomerular capillary endothelial fenestration in human type 1 diabetic nephropathy","volume":"56","author":"M Toyoda","year":"2007","journal-title":"Diabetes"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1681\/ASN.2011121170","article-title":"eNOS deficiency predisposes podocytes to injury in diabetes","volume":"23","author":"DA Yuen","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"e64650","DOI":"10.1371\/journal.pone.0064650","article-title":"Endothelial nitric oxide synthase reduces crescentic and necrotic glomerular lesions, reactive oxygen production, and MCP1 production in murine lupus nephritis","volume":"8","author":"GS Gilkeson","year":"2013","journal-title":"PLoS ONE"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1111\/j.1476-5381.2010.01158.x","article-title":"Chronic administration of BMS309403 improves endothelial function in apolipoprotein E-deficient mice and in cultured human endothelial cells","volume":"162","author":"MY Lee","year":"2011","journal-title":"Br J Pharmacol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s00380-010-0060-x","article-title":"Olmesartan reduces arterial stiffness and serum adipocyte fatty acid-binding protein in hypertensive patients","volume":"26","author":"T Miyoshi","year":"2011","journal-title":"Heart Vessels"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Furuhashi M, Mita T, Moniwa N, Hoshina K, Ishimura S, <etal>et al<\/etal>. (2014) Angiotensin II receptor blockers decrease serum concentration of fatty acid-binding protein 4 in patients with hypertension. Hypertens Res (in press).","DOI":"10.1038\/hr.2015.2"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1365-2362.2007.01835.x","article-title":"Treatment with atorvastatin reduces serum adipocyte-fatty acid binding protein value in patients with hyperlipidaemia","volume":"37","author":"M Karpisek","year":"2007","journal-title":"Eur J Clin Invest"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0115429","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,24]],"date-time":"2022-04-24T12:10:03Z","timestamp":1650802203000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0115429"}},"subtitle":[],"editor":[{"given":"Ines","family":"Armando","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,12,15]]},"references-count":42,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,12,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0115429","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,15]]}}}